What do early stage companies really need to focus on? Patent attorney David Dykeman says, first and foremost, that it’s intellectual property protection. Dykeman –who co-chairs Greenberg Traurig’s global Life Sciences & Medical Technology Group – will speak at DeviceTalks Boston on October 2. We asked him to give us some ideas on the important issues surrounding […]
When it comes to defending product liability lawsuits, it’s tough to top Greenberg Traurig’s Lori Cohen and her 98.3% winning percentage – she’s 57-for-58 lifetime in the courtroom.* Cohen, a shareholder at the law firm, is chairwoman of GT’s pharmaceutical, medical device & healthcare litigation practice and its trial practice group. Based in Atlanta, she’s saved her medical […]
By David Dykeman and David Peck
Last year was a banner year for medtech investment and mergers & acquisitions, as companies busted out of the recession in style.
MASSDEVICE ON CALL — Advocate groups for autism, a disease which now affects 1 in 88 U.S. children, are disappointed with the Obama administration’s decision to leave autism coverage up to each state.
Nearly 300 of the industry’s best and brightest gathered for a night of big ideas, industry insights and few cocktails last night at MassDevice.com’s Big 100 East 2013 conference in Waltham, Mass.
Dr. Richard Gilfillan, the 1st leader of the recently-created Center for Medicare & Medicaid Services Innovation Center, will hand over the reigns at the end of the month, and no replacement has yet been named.
The Irvine, Calif.-based medical device company said Abate, 60, will stay on as CFO while the search goes on. Edwards hired Peter Crist of Crist/Kolder Associates to assist in the quest, according to a press release.
Mako Surgical (NSDQ:MAKO) tapped Lawrence Gibbons to replace its regulatory affairs vice president, James Keller, who resigned effective Feb. 3.
Gibbons, 60, was most recently with Fisher & Paykel Healthcare (NZE:FPH), where he helped establish a manufacturing facility in Mexico and set up the quality system at the company’s New Zealand headquarters.
This week President Barack Obama is expected to sign a patent reform bill marking the most dramatic changes to the patent system in decades, drawing adulation and ire from varying sectors of the innovation economy.
The American Invents Act, six years in the making, contains several sweeping changes, but the main bone of contention is a transformation of the U.S. patent system from a first-to-invent application process to a first-to-file process.
The U.S. is on the verge of the largest shift the patent system has seen in decades as President Barack Obama prepares to sign a bill that will transform the process from a first-to-invent system to a first-to-file system.
The "America Invents Act," six years in the making, passed the Senate last week in a sweeping 89 to 9 vote accepting the bill, having won House approval in a similarly large landslide in March.